Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The complestatins as HIV-1 integrase inhibitors. Efficient isolation, structure elucidation, and inhibitory activities of isocomplestatin, chloropeptin I, new complestatins, A and B, and acid-hydrolysis products of chloropeptin I.
Singh SB, Jayasuriya H, Salituro GM, Zink DL, Shafiee A, Heimbuch B, Silverman KC, Lingham RB, Genilloud O, Teran A, Vilella D, Felock P, Hazuda D. Singh SB, et al. Among authors: vilella d. J Nat Prod. 2001 Jul;64(7):874-82. doi: 10.1021/np000632z. J Nat Prod. 2001. PMID: 11473415
Oreganic acid, a potent inhibitor of ras farnesyl-protein transferase.
Silverman KC, Jayasuriya H, Cascales C, Vilella D, Bills GF, Jenkins RG, Singh SB, Lingham RB. Silverman KC, et al. Among authors: vilella d. Biochem Biophys Res Commun. 1997 Mar 17;232(2):478-81. doi: 10.1006/bbrc.1997.6314. Biochem Biophys Res Commun. 1997. PMID: 9125205
Resorcylic acid lactones: naturally occurring potent and selective inhibitors of MEK.
Zhao A, Lee SH, Mojena M, Jenkins RG, Patrick DR, Huber HE, Goetz MA, Hensens OD, Zink DL, Vilella D, Dombrowski AW, Lingham RB, Huang L. Zhao A, et al. Among authors: vilella d. J Antibiot (Tokyo). 1999 Dec;52(12):1086-94. doi: 10.7164/antibiotics.52.1086. J Antibiot (Tokyo). 1999. PMID: 10695671 Free article.
Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.
Zhang B, Salituro G, Szalkowski D, Li Z, Zhang Y, Royo I, Vilella D, Díez MT, Pelaez F, Ruby C, Kendall RL, Mao X, Griffin P, Calaycay J, Zierath JR, Heck JV, Smith RG, Moller DE. Zhang B, et al. Among authors: vilella d. Science. 1999 May 7;284(5416):974-7. doi: 10.1126/science.284.5416.974. Science. 1999. PMID: 10320380
Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real-word study on aducanumab and lecanemab.
Logroscino G, Urso D, Gnoni V, Giugno A, Vilella D, Castri A, Barone R, Nigro S, Zecca C, De Blasi R, Introna A. Logroscino G, et al. Among authors: vilella d. Eur J Neurol. 2025 Jan;32(1):e16534. doi: 10.1111/ene.16534. Epub 2024 Nov 5. Eur J Neurol. 2025. PMID: 39498901 Free PMC article.
Nocturnal sleep dynamics alterations in the early stages of behavioral variant frontotemporal dementia.
Gnoni V, Tamburrino L, Baldazzi G, Urso D, Zoccolella S, Giugno A, Figorilli M, Nigro S, Tafuri B, Vilella D, Vitulli A, Zecca C, Dell'Abate MT, Pani D, Puligheddu M, Rosenzweig I, Filardi M, Logroscino G. Gnoni V, et al. Among authors: vilella d. Sleep. 2025 Jan 13;48(1):zsae201. doi: 10.1093/sleep/zsae201. Sleep. 2025. PMID: 39271187 Free PMC article.
39 results